HEME Hospice - Home Transfusion Program

Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial

What's the purpose of the trial?

This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies.
Trial status

Not yet accepting

Type
Supportive
Enrollment
700
Last Updated
4 weeks ago

Participating Centers

There are 2 centers participating in this trial. Enter a location below to find the closest center.

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Not yet accepting

Arm 1: HEME-Hospice Care

Not yet accepting

Arm 2: Usual Care

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.